Insurance barriers limit access to blood cancer drugs

Patients with humor cancers often look large security hurdles and important out-of-pocket costs erstwhile trying to entree specialty oral anticancer medications, according to a caller nationwide survey led by researchers astatine the Perelman School of Medicine astatine the University of Pennsylvania.